快而精医药(QGEN)

50.35 -0.11 -0.218%

今开:49.98昨收:50.46
最高:50.5 最低:49.73
涨停价:0.0跌停价:0.0
总市值:1.1464695E10

快而精医药的热门评论

美股滚雪球2021-11-04 11:25

有报道称$快而精医药(QGEN)$ 吸引了法国诊断公司bioMérieux的收购兴趣。
去年,$赛默飞世尔科技(TMO)$ 出价104亿欧元收购QGEN,但最终交易破裂,一周后Qigen董事长辞职,这次董事长还辞职吗?
$东方生物(SH688298)$查看全文

美股滚雪球2021-11-17 12:09

$赛默飞世尔科技(TMO)$ 据说又想并购$快而精医药(QGEN)$ 了,念念不忘,必有回响。$义翘神州(SZ301047)$查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)11-09 19:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接查看全文

7X24快讯2021-07-12 23:14

市场消息:快而精医药(QGEN.N)将回购高达1亿美元股票。查看全文

JZee2021-06-21 09:41

$泛生子(GTH)$ 主页上有$快而精医药(QGEN)$ 合作字样。泛生子目前的检测服务和未来的肝癌早筛需给qiagen分成么?//@userfield:回复@张小丰:我倒是觉得这个行业现在不需要一口吃个胖子吧,应该是渐进式进步,先比临床日常用的检测方法有更好的灵敏度和特异性,然后采样方便,这样就有一定优势,可以...查看全文

财报披露

快而精医药(QGEN)07-29 18:06

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接查看全文

财报披露

快而精医药(QGEN)07-28 18:12

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接查看全文

快而精医药(QGEN)2021-05-05 18:42

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-21-000031 Act: 34 Size: 1 MB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的最新评论

快而精医药(QGEN)2020-08-05 18:10

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000039 Act: 34 Size: 53 MB 网页链接查看全文

快而精医药(QGEN)2020-08-05 18:10

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000041 Act: 34 Size: 677 KB 网页链接查看全文

快而精医药(QGEN)2020-08-05 18:10

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-20-000043 Act: 34 Size: 1 MB 网页链接查看全文

快而精医药(QGEN)2020-08-04 04:35

$快而精医药(QGEN)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0000902664-20-002857 Act: 34 Size: 153 KB 网页链接查看全文

快而精医药(QGEN)2020-08-04 04:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-089609 Act: 34 Size: 129 KB 网页链接查看全文

美股滚雪球2020-08-03 09:21

西门子并购$瓦里安医疗系统(VAR)$ :164亿美元,这是今年迄今为止最大的并购,超过了$赛默飞世尔科技(TMO)$ 以125亿美元并购$快而精医药(QGEN)$查看全文

快而精医药(QGEN)2020-07-28 05:15

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-086884 Act: 34 Size: 127 KB 网页链接查看全文

快而精医药(QGEN)2020-07-23 21:30

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-085835 Act: 34 Size: 131 KB 网页链接查看全文

快而精医药(QGEN)2020-07-22 18:20

$快而精医药(QGEN)$ SC 14D9/A [Amend] Solicitation, recommendation statements Accession Number: 0001193125-20-196750 Act: 34 Size: 904 KB 网页链接查看全文

快而精医药(QGEN)2020-07-21 04:10

$快而精医药(QGEN)$ SC TO-T/A [Amend] Tender offer statement by Third Party Accession Number: 0001104659-20-084838 Act: 34 Size: 125 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

快而精医药的公告

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000047 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000042 Act: 34 Size: 7 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000045 Act: 34 Size: 544 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000040 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000037 Act: 34 Size: 533 KB 网页链接

专项披露公告

$快而精医药(QGEN)$ SD Specialized disclosure report Accession Number: 0001015820-22-000031 Act: 34 Size: 44 KB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000026 Act: 34 Size: 1 MB 网页链接

财报披露

$快而精医药(QGEN)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001015820-22-000024 Act: 34 Size: 443 KB 网页链接

定期披露文件

$快而精医药(QGEN)$ IRANNOTICE Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)). Accession Number: 0001015820-22-000020 Act: 34 Size: 102 KB 网页链接

年度财报

$快而精医药(QGEN)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001015820-22-000017 Act: 34 Size: 24 MB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30